Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT

11Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We generated transgenic mice bearing a tamoxifen-dependent Cre recombinase expressed under the control of the dopamine-β-hydroxylase promoter. By crossing to the ROSA26 reporter mice we show that tamoxifen-induced Cre recombinase in adult mice specifically activates β-galactosidase expression in differentiated noradrenergic neurons of the central and peripheral nervous system. Tamoxifen application in adult mice did not induce β-galactosidase activity in parasympathetic neurons that transiently express DBH during development. Thus, this transgenic mouse line represents a valuable tool to study gene function in mature noradrenergic neurons by conditional inactivation. © 2011 Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

Stubbusch, J., Majdazari, A., Schmidt, M., Schütz, G., Deller, T., & Rohrer, H. (2011). Generation of the tamoxifen-inducible DBH-Cre transgenic mouse line DBH-CT. Genesis, 49(12), 935–941. https://doi.org/10.1002/dvg.20773

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free